This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuster, V. Articles by Chesebro, J. H. Search for Related Content PubMed PubMed Citation Articles by Fuster, V. Articles by Chesebro, J. H.

Circulation, Vol 60, 1508-1512, Copyright © 1979 by American Heart Association

ARTICLES

Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors

V Fuster, MK Dewanjee, MP Kaye, M Josa, MP Metke and JH Chesebro

At 8 and 32 hours after saphenous vein bypass graft surgery in six dogs, in vivo images of the graft were obtained with a gamma camera after intravenous injection, 2 hours postoperatively of autologous platelets labeled with indium-111. Platelet deposition in the grafts could be imaged in vivo from the scintiphotos. In vitro images of the excised heart showed saphenous vein graft uptake confirming the in vivo image. In vitro determination of radioactivity in the graft averaged 17 +/- 14 times greater than in blood and 33 +/- 26 times greater than in the lung. Under identical conditions, in eight dogs treated with dipyridamole (55 mg/day) plus aspirin (325 mg/day), the grafts appeared to have considerably less platelet deposition as estimated by imaging. In vitro determination of radioactivity in the graft averaged 5 +/- 2 times greater than in blood and 8 +/- 4 times greater than in the lung (p less than 0.01). This noninvasive technique may be a promising tool for a better understanding of the role played by platelets in the process of occlusion of saphenous vein bypass grafts in man and its prevention with platelet inhibotors.

This article has been cited by other articles:

				K. A. Bybee, B. D. Powell, U. Valeti, A. G. Rosales, S. L. Kopecky, C. Mullany, and R. S. Wright Preoperative Aspirin Therapy Is Associated With Improved Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Circulation, August 30, 2005; 112(9_suppl): I-286 - I-292. [Abstract] [Full Text] [PDF]

				F. C. Tanner, T. Largiader, H. Greutert, Z. Yang, and T. F. Luscher Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 20 - 26. [Abstract] [Full Text] [PDF]

				J. H. Chesebro, V. Fuster, F. J. Pugo, W. Karzai, H.-J. Priebe, and D. T. Mangano Aspirin and Mortality from Coronary Bypass Surgery N. Engl. J. Med., March 13, 2003; 348(11): 1057 - 1059. [Full Text] [PDF]

				R. J. Dilley, J. K. McGeachie, and F. J. Prendergast A Review of the Histologic Changes in Vein-to-Artery Grafts, With Particular Reference to Intimal Hyperplasia Arch Surg, June 1, 1988; 123(6): 691 - 696. [Abstract] [PDF]